XTRA:MRKPharmaceuticals
Merck KGaA (XTRA:MRK) Margin Decline Challenges Bullish Profit Expansion Narrative
Merck KGaA (XTRA:MRK) has reported Q1 2026 revenue of €5.1b and basic EPS of €1.52, with the trailing twelve month figures sitting at €21.0b of revenue and EPS of €5.83. Over recent quarters, revenue has moved from €5.28b in Q1 2025 to €5.25b in Q2 2025, €5.32b in Q3 2025 and €5.25b in Q4 2025, while EPS shifted from €1.69 to €1.50, €2.07 and €0.73 across the same periods. This gives investors a clearer view of how the top and bottom line have tracked into this latest print. With a net profit...